Sophie Papa is a Clinical Reader in Immune-oncology and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust (GSTT). Sophie undertook her medical training at the University of Oxford and Imperial College London. She completed a PhD in solid tumour CAR T-cell cancer immunotherapy from King’s College London in 2011. She is a clinical academic with research interests in the field of immune-oncology. Her group have two areas of study: Firstly, strategies to enhance CAR T-cell clinical translation and secondly, cohort based investigation of mechanism of checkpoint inhibitor driven inflammatory disease. Sophie is a medical oncologist with a practice in malignant melanoma and Merkle cell carcinoma. As a principal investigator in the GSTT Early Phase Trials Team Sophie has expertise in the design and delivery of first in man studies. She has a particular focus on building skills and capabilities to deliver immune effector cell therapies for solid tumours. She is the lead for skin cancer research and chairs the biological safety committee.